Thiamine-responsive megaloblastic anemia (Rogers syndrome; OMIM #249270) is a rare autosomal recessive disorder caused by pathogenic variants in the SLC19A2 gene, which encodes the high-affinity thiamine transporter type 1. The disease is characterized by the classic triad of symptoms: megaloblastic anemia, non-autoimm...
M. Gurzhikhanova, T. Salimova, O. Goronkova et al.· Pediatric Hematology/Oncolog...· 0 citations
Performing allo-HSCT before the development of advanced clonal evolution and malignant transformation is associated with improved long-term outcomes, suggesting a personalized approach based on the underlying genetic defect, clinical disease course, and evidence of clonal evolution allows for timely transplantation and...
M. S. Vasilyeva, A. Maschan, E. Raykina et al.· Pediatric Hematology/Oncolog...· 0 citations
The findings highlight the importance of early molecular genetic testing in children with persistent hematopoietic abnormalities, along with regular cytogenetic surveillance and timely referral of high-risk patients for HSCT.
M. S. Vasilyeva, A. Pavlova, D. Fedorova et al.· Pediatric Hematology/Oncolog...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.